| 1 |
33670025 | The Relevance of Noncoding DNA Variations of Paraoxonase Gene Cluster in Atherosclerosis-Related Diseases. | 2021 Feb 21 |
1 |
| 2 |
31832570 | Dysregulated Lipid Transport Proteins Correlate With Pathogenesis and Outcome in Severe Alcoholic Hepatitis. | 2019 Dec |
2 |
| 3 |
28742600 | Cholesterol reduction and macrophage function: role of paraoxonases. | 2017 Oct |
1 |
| 4 |
26567339 | Identification of Critical Paraoxonase 1 Residues Involved in High Density Lipoprotein Interaction. | 2016 Jan 22 |
2 |
| 5 |
27633038 | Pharmacological Interactions of Paraoxonase 1 (PON1): A HDL-Bound Antiatherogenic Enzyme. | 2016 |
1 |
| 6 |
27668323 | Association of paraoxonase 1 (PON1) gene polymorphisms and concentration with essential hypertension. | 2016 |
2 |
| 7 |
25304213 | Novel nucleophiles enhance the human serum paraoxonase 1 (PON1)-mediated detoxication of organophosphates. | 2015 Jan |
2 |
| 8 |
25038995 | Systemic inflammation, intestine, and paraoxonase-1. | 2014 |
1 |
| 9 |
23508039 | Paraoxonase 1 activities, regulation, and interactions with atherosclerotic lesion. | 2013 Aug |
1 |
| 10 |
23973798 | Oxidized-phospholipids in reconstituted high density lipoprotein particles affect structure and function of recombinant paraoxonase 1. | 2013 Dec |
2 |
| 11 |
22067439 | The anti-inflammatory effect of paraoxonase 1 against oxidized lipids depends on its association with high density lipoproteins. | 2012 Jan 2 |
1 |
| 12 |
21187701 | Association of Paraoxonase 1 (PON1) polymorphisms with osteoporotic fracture risk in postmenopausal Korean women. | 2011 Feb 28 |
2 |
| 13 |
20221878 | Paraoxonase 1 interactions with HDL, antioxidants and macrophages regulate atherogenesis - a protective role for HDL phospholipids. | 2010 |
1 |
| 14 |
20221879 | The effect of HDL mimetic peptide 4F on PON1. | 2010 |
2 |
| 15 |
20470383 | Decreased paraoxonase-1 activity is associated with alterations of high-density lipoprotein particles in chronic liver impairment. | 2010 May 14 |
1 |
| 16 |
19204840 | Assessment of serum paraoxonase and arylesterase activities in early pregnancy failure. | 2009 Feb 7 |
2 |
| 17 |
19399923 | Measurement of serum paraoxonase-1 activity in the evaluation of liver function. | 2009 Apr 28 |
1 |
| 18 |
19764813 | Dramatic differences in organophosphorus hydrolase activity between human and chimeric recombinant mammalian paraoxonase-1 enzymes. | 2009 Nov 3 |
1 |
| 19 |
18669160 | Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease. | 2008 |
1 |
| 20 |
17359486 | Genetic and environmental determinants of the PON-1 phenotype. | 2007 Mar |
1 |
| 21 |
17460182 | Age-related paraoxonase activity changes in Turkish population. | 2007 Apr |
2 |
| 22 |
16353344 | Paraoxonase (PON1): from toxicology to cardiovascular medicine. | 2005 |
1 |
| 23 |
14579013 | Pharmacogenetics of paraoxonases: a brief review. | 2004 Jan |
1 |
| 24 |
15046624 | Correlation studies of plasma paraoxonase activity and uric acid concentration with AAPH-Induced erythrocyte hemolysis in hemodialysis patients. | 2004 Mar |
1 |
| 25 |
15163466 | Paraoxonase 1 and platelet-activating factor acetylhydrolase activities in patients with low hdl-cholesterol levels with or without primary hypertriglyceridemia. | 2004 May-Jun |
1 |
| 26 |
15265000 | Genetic and environmental factors modulating serum concentrations and activities of the antioxidant enzyme paraoxonase-1. | 2004 Nov |
2 |
| 27 |
15306175 | Effects of intravenous apolipoprotein A-I/phosphatidylcholine discs on paraoxonase and platelet-activating factor acetylhydrolase in human plasma and tissue fluid. | 2004 Sep |
2 |
| 28 |
12466264 | Platelet-activating factor acetylhydrolase, and not paraoxonase-1, is the oxidized phospholipid hydrolase of high density lipoprotein particles. | 2003 Feb 7 |
1 |
| 29 |
12504832 | Paraoxonase-1 reduces monocyte chemotaxis and adhesion to endothelial cells due to oxidation of palmitoyl, linoleoyl glycerophosphorylcholine. | 2003 Jan |
1 |
| 30 |
12871208 | Beneficial effect of oleoylated lipids on paraoxonase 1: protection against oxidative inactivation and stabilization. | 2003 Oct 15 |
3 |
| 31 |
12433026 | The risk of coronary artery disease in population of Taiwan is associated with Cys-Ser 311 polymorphism of human paraoxonase (PON)-2 gene. | 2002 Sep |
2 |
| 32 |
11171072 | Hydrolysis of platelet-activating factor by human serum paraoxonase. | 2001 Feb 15 |
2 |
| 33 |
11320335 | [Human plasma paraoxonase (HuPON1): an anti-atherogenic enzyme with organophosphate hydrolase activity]. | 2001 Apr |
1 |
| 34 |
11378531 | Lipid peroxidation is increased in paraoxonase L55 homozygotes compared with M-allele carriers. | 2001 May |
1 |
| 35 |
11724654 | High-density lipoprotein composition and paraoxonase activity in Type I diabetes. | 2001 Dec |
1 |
| 36 |
10232833 | Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. | 1999 Apr |
1 |
| 37 |
9739487 | Paraoxonase and coronary heart disease. | 1998 Aug |
1 |
| 38 |
9746266 | Paraoxonase as a risk marker for cardiovascular disease: facts and hypotheses. | 1998 Jun |
1 |
| 39 |
9763535 | Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R. | 1998 Oct |
1 |
| 40 |
8812495 | Structural organization of the human PON1 gene. | 1996 Aug 1 |
1 |
| 41 |
8675659 | Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein. | 1995 Dec |
2 |